LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+5.43%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.57B
AUM Growth
+$1.57B
(-2.7%)
Cap. Flow
-$30.3M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
432
New
226
Increased
52
Reduced
94
Closed
41
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$22.4M |
| 2 |
CRISPR Therapeutics
CRSP
|
$13.5M |
| 3 |
Virtus Investment Partners
VRTS
|
$11.9M |
| 4 |
Amazon
AMZN
|
$11.8M |
| 5 |
Medifast
MED
|
$11.5M |
Top Sells
| 1 |
Merck
MRK
|
$27.7M |
| 2 |
Voya Financial
VOYA
|
$24.9M |
| 3 |
Equity Lifestyle Properties
ELS
|
$23.4M |
| 4 |
BioNTech
BNTX
|
$16.1M |
| 5 |
iShares MSCI India ETF
INDA
|
$15.5M |
Sector Composition
| 1 | Healthcare | 52.77% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Financials | 13.41% |
| 4 | Technology | 7.21% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $40.7M | 2.6% |
81,123
+13,805
| +21% | +$6.93M |
|
2
Abbott
ABT
$231B
| $40.6M | 2.59% |
288,654
+79,180
| +38% | +$11.1M |
|
|
CIXX
3
DELISTED
CI Financial Corp.
CIXX
| $39.7M | 2.53% |
1,500,000
+847,191
| +130% | +$22.4M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $38.5M | 2.46% |
57,692
-5,528
| -9% | -$3.69M |
|
5
IQVIA
IQV
$32.4B
| $37.5M | 2.39% |
132,889
-15,512
| -10% | -$4.38M |
|
|
6
Medifast
MED
$154M
| $36.7M | 2.34% |
175,000
+55,000
| +46% | +$11.5M |
|
7
AbbVie
ABBV
$372B
| $32.2M | 2.05% |
237,484
+21,345
| +10% | +$2.89M |
|
8
Service Corp International
SCI
$11.1B
| $31.9M | 2.04% |
450,000
-50,000
| -10% | -$3.55M |
|
9
Ameriprise Financial
AMP
$48.5B
| $30.6M | 1.95% |
101,282
-877
| -0.9% | -$265K |
|
10
Brunswick
BC
$4.15B
| $30.2M | 1.93% |
300,000
+41,620
| +16% | +$4.19M |
|
11
GoodRx Holdings
GDRX
$1.51B
| $30M | 1.91% |
917,273
-91,628
| -9% | -$2.99M |
|
12
Tandem Diabetes Care
TNDM
$845M
| $29.1M | 1.86% |
193,161
-63,695
| -25% | -$9.59M |
|
13
Labcorp
LH
$23.1B
| $28.7M | 1.83% |
91,212
-9,990
| -10% | -$3.14M |
|
14
American Express
AXP
$231B
| $28.6M | 1.83% |
174,803
+3,488
| +2% | +$571K |
|
15
Pultegroup
PHM
$26B
| $28.6M | 1.82% |
500,000
+24,266
| +5% | +$1.39M |
|
|
LHCG
16
DELISTED
LHC Group LLC
LHCG
| $27.4M | 1.75% |
200,000
+70,000
| +54% | +$9.61M |
|
17
Lowe's Companies
LOW
$145B
| $27.3M | 1.74% |
105,552
-26,915
| -20% | -$6.96M |
|
18
Chemed
CHE
$6.67B
| $26.5M | 1.69% |
50,000
| – | – |
|
19
Charles Schwab
SCHW
$174B
| $26M | 1.66% |
308,572
-30,437
| -9% | -$2.56M |
|
20
Thor Industries
THO
$5.79B
| $25.9M | 1.66% |
250,000
+50,000
| +25% | +$5.19M |
|
|
IMGN
21
DELISTED
Immunogen Inc
IMGN
| $25.6M | 1.63% |
3,443,524
+430,057
| +14% | +$3.19M |
|
22
Keysight
KEYS
$28.1B
| $25.5M | 1.63% |
123,599
-32,578
| -21% | -$6.73M |
|
23
Visa
V
$683B
| $25.1M | 1.6% |
115,971
+32
| +0% | +$6.94K |
|
24
Hologic
HOLX
$14.9B
| $25M | 1.6% |
326,434
-77,337
| -19% | -$5.92M |
|
25
Biogen
BIIB
$19.4B
| $24.6M | 1.57% |
102,484
+18,138
| +22% | +$4.35M |
|